These	DT	det	O
results	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
chemotherapeutic	JJ	amod	O
implications	NNS	dobj	O
for	IN	mark	O
using	VBG	advcl	O
emodin	NN	dobj	B-Simple_chemical
to	TO	mark	O
target	VB	xcomp	O
HER	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
neu	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
two	CD	nsubj	O
of	IN	case	O
35	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
median	JJ	amod	O
age	NN	dep	O
,	,	punct	O
62	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
evaluable	JJ	appos	O
for	IN	case	O
response	NN	nmod	O
.	.	punct	O

Molecular	JJ	amod	O
mediators	NNS	ROOT	O
of	IN	case	O
interactions	NNS	nmod	O
with	IN	case	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
components	NNS	nmod	I-Cellular_component
in	IN	case	O
metastasis	NN	nmod	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Loss	NN	nsubj	O
of	IN	case	O
p21	NN	nmod	B-Gene_or_gene_product
completely	RB	advmod	O
abolished	VBD	ROOT	O
the	DT	det	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	compound	O
function	NN	dobj	O
of	IN	case	O
p53R172P	NNS	nmod	B-Gene_or_gene_product
and	CC	cc	O
accelerated	VBD	conj	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
in	IN	case	O
Trp53	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
.	.	punct	O

[	-LRB-	punct	O
Intraepithelial	JJ	amod	B-Cancer
neoplasm	NN	ROOT	I-Cancer
of	IN	case	O
the	DT	det	O
uterine	NN	amod	B-Multi-tissue_structure
cervix	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
angiogenesis	NN	conj	O
:	:	punct	O
morphologic	JJ	amod	O
study	NN	dep	O
]	-RRB-	punct	O

We	PRP	nsubj	O
especially	RB	advmod	O
focused	VBD	ROOT	O
on	IN	case	O
the	DT	det	O
role	NN	nmod	O
of	IN	case	O
Crk	NN	compound	B-Gene_or_gene_product
adaptor	NN	compound	O
protein	NN	nmod	O
in	IN	case	O
EphB	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
mediated	VBN	amod	O
signaling	NN	nmod	O
.	.	punct	O

The	DT	det	O
transformed	VBN	amod	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
cloned	VBN	ROOT	O
after	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
tumorigenic	JJ	amod	O
assay	NN	nmod	O
,	,	punct	O
and	CC	cc	O
4	CD	nummod	O
clones	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
analyzed	VBN	conj	O
for	IN	case	O
osteonectin	NN	amod	B-Gene_or_gene_product
expression	NN	nmod	O
by	IN	case	O
Northern	NN	compound	O
blots	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
D2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
40	CD	intj	I-Gene_or_gene_product
+	CC	cc	O
LVI	NN	conj	O
and	CC	cc	O
age	NN	conj	O
,	,	punct	O
t	NN	compound	O
-	HYPH	punct	O
stage	NN	intj	O
,	,	punct	O
nodal	JJ	amod	O
status	NN	conj	O
,	,	punct	O
grading	NN	compound	O
and	CC	cc	O
hormonreceptor	NN	compound	O
-	HYPH	punct	O
status	NN	nmod	O
.	.	punct	O

MDM2	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubjpass	O
was	VBD	auxpass	O
manually	RB	advmod	O
classified	VBN	ROOT	O
as	IN	case	O
>	NN	amod	O
5	CD	nummod	O
%	NN	amod	O
nuclear	JJ	amod	B-Cellular_component
staining	NN	nmod	O
.	.	punct	O

Mechanisms	NNS	ROOT	O
for	IN	case	O
the	DT	det	O
magnolol	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	nmod	O
of	IN	case	O
CGTH	NN	compound	B-Cell
W	NNP	compound	I-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
thyroid	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
although	IN	mark	O
beta	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
2	LS	dep	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
M	NN	nsubjpass	I-Gene_or_gene_product
and	CC	cc	O
MHC	NN	compound	B-Gene_or_gene_product
class	NN	conj	I-Gene_or_gene_product
I	PRP	nummod	I-Gene_or_gene_product
are	VBP	auxpass	O
expressed	VBN	advcl	O
on	IN	case	O
normal	JJ	amod	O
hematopoietic	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
potential	JJ	amod	O
safety	NN	compound	O
concern	NN	acl:relcl	O
,	,	punct	O
the	DT	det	O
monoclonal	JJ	amod	O
antibodies	NNS	nsubj	O
were	VBD	cop	O
selective	JJ	ROOT	O
to	TO	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
did	VBD	aux	O
not	RB	neg	O
damage	VB	conj	O
normal	JJ	amod	O
cells	NNS	dobj	B-Cell
in	FW	compound	O
vitro	FW	advmod	O
or	CC	advmod	O
in	IN	case	O
human	JJ	conj	B-Organism
-	HYPH	punct	O
like	IN	case	O
mouse	NN	compound	B-Organism
models	NNS	nmod	O
.	.	punct	O

The	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
anomalies	NNS	nsubj	O
seem	VBP	ROOT	O
to	TO	mark	O
precede	VB	xcomp	O
the	DT	det	O
development	NN	dobj	O
of	IN	prep	O
histologic	JJ	amod	B-Pathological_formation
lesions	NNS	pobj	I-Pathological_formation
in	IN	prep	O
some	DT	det	O
instances	NNS	pobj	O
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
reagent	NN	compound	O
TNP	NNP	compound	B-Simple_chemical
-	:	punct	I-Simple_chemical
470	CD	nmod	I-Simple_chemical
suppressed	VBD	ROOT	O
postoperative	JJ	amod	O
progression	NN	dobj	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

A	DT	det	O
third	JJ	amod	O
mutation	NN	nsubj	O
involved	VBD	ROOT	O
a	DT	det	O
single	JJ	amod	O
base	NN	compound	O
pair	NN	compound	O
(	-LRB-	punct	O
adenine	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
deletion	NN	dobj	O
in	IN	case	O
codon	NN	nmod	O
3	CD	nummod	O
of	IN	case	O
H	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	nmod	I-Gene_or_gene_product
which	WDT	nsubj	O
causes	VBZ	acl:relcl	O
a	DT	det	O
frame	NN	compound	O
shift	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
a	DT	det	O
termination	NN	compound	O
signal	NN	nmod	O
at	IN	case	O
codon	NN	nmod	O
19	CD	nummod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
pathologic	JJ	amod	O
analysis	NN	nmod	O
of	IN	prep	O
the	DT	det	O
abdominal	JJ	amod	B-Pathological_formation
wounds	NNS	pobj	I-Pathological_formation
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
statistically	RB	advmod	O
significant	JJ	amod	O
difference	NN	nsubj	O
between	IN	case	O
any	DT	nmod	O
of	IN	case	O
the	DT	det	O
groups	NNS	nmod	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
,	,	punct	O
regarding	VBG	advcl	O
inflammation	NN	dobj	O
.	.	punct	O

One	CD	nummod	O
example	NN	nsubj	O
of	IN	prep	O
particular	JJ	amod	O
interest	NN	pobj	O
is	VBZ	ROOT	O
the	DT	det	O
Keap1	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Nrf2	NN	compound	B-Gene_or_gene_product
system	NN	attr	O
since	IN	prep	O
,	,	punct	O
according	VBG	prep	O
to	IN	prep	O
recent	JJ	amod	O
studies	NNS	pobj	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
turned	VBN	advcl	O
out	RP	prt	O
to	TO	aux	O
be	VB	xcomp	O
ambivalent	JJ	acomp	O
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
double	JJ	amod	O
staining	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
used	VBN	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
expression	NN	dobj	O
in	IN	case	O
TAMs	NN	nmod	B-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
all	DT	nsubj	O
of	IN	case	O
the	DT	det	O
endometrial	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
lost	VBD	ROOT	O
normal	JJ	amod	O
DCC	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

High	NNP	compound	O
-	HYPH	punct	O
Dose	NNP	compound	O
celecoxib	NN	nsubj	B-Simple_chemical
and	CC	cc	O
metronomic	JJ	amod	O
"	``	punct	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	conj	O
"	''	punct	O
cyclophosphamide	NN	appos	B-Simple_chemical
is	VBZ	cop	O
an	DT	det	O
effective	JJ	amod	O
and	CC	cc	O
safe	JJ	conj	O
therapy	NN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
relapsed	JJ	amod	O
and	CC	cc	O
refractory	JJ	conj	O
aggressive	JJ	amod	O
histology	NN	nmod	O
non	NN	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	dep	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	dep	I-Cancer
.	.	punct	O

Histopathological	JJ	amod	O
development	NN	ROOT	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
tumors	NNS	nmod	I-Cancer
induced	VBN	acl	O
by	IN	case	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitro	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosoguanidine	NN	nmod	I-Simple_chemical
in	IN	case	O
rats	NNS	nmod	B-Organism
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
also	RB	advmod	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
both	DT	conj	O
of	IN	case	O
its	PRP$	nmod:poss	O
receptors	NNS	nmod	O
flt	IN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
4	CD	attr	I-Gene_or_gene_product
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
006	CD	attr	O
)	-RRB-	punct	O
and	CC	cc	O
KDR	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
03	CD	attr	O
)	-RRB-	punct	O
but	CC	cc	O
no	DT	neg	O
association	NN	conj	O
between	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
B	NNP	nmod	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
receptor	NN	conj	O
flt	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
23	CD	attr	O
)	-RRB-	punct	O
.	.	punct	O

High	JJ	amod	O
density	NN	ROOT	O
of	IN	case	O
somatostatin	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
in	IN	case	O
veins	NNS	nmod	B-Multi-tissue_structure
surrounding	VBG	acl	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Tissue
tissue	NN	dobj	I-Tissue
:	:	punct	O
role	NN	dep	O
in	IN	case	O
tumor	NN	compound	B-Cancer
-	HYPH	punct	O
host	NN	compound	O
interaction	NN	nmod	O
?	.	punct	O

The	DT	det	O
lack	NN	nsubj	O
of	IN	case	O
treatment	NN	nmod	O
for	IN	case	O
worried	JJ	amod	O
-	HYPH	punct	O
well	JJ	intj	O
patients	NNS	nmod	B-Organism
with	IN	case	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
prostatic	JJ	amod	B-Pathological_formation
intraepithelial	JJ	amod	I-Pathological_formation
neoplasia	NN	nmod	I-Pathological_formation
combined	VBN	acl	O
with	IN	prep	O
issues	NNS	pobj	O
of	IN	prep	O
recurrence	NN	compound	O
and	CC	cc	O
hormone	NN	conj	O
resistance	NN	pobj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
survivors	NNS	nmod	O
remains	VBZ	ROOT	O
a	DT	det	O
major	JJ	amod	O
public	JJ	amod	O
health	NN	compound	O
obstacle	NN	dobj	O
.	.	punct	O

Eligible	JJ	amod	O
patients	NNS	nsubj	B-Organism
had	VBD	ROOT	O
CNV	NN	nsubj	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
central	JJ	amod	O
boundary	NN	nsubj	O
of	IN	prep	O
the	DT	det	O
lesion	NN	pobj	B-Pathological_formation
was	VBD	cop	O
between	IN	case	O
1	CD	nummod	O
and	CC	cc	O
199	CD	conj	O
microm	NN	dobj	O
from	IN	case	O
the	DT	det	O
geometric	JJ	amod	O
center	NN	nmod	O
of	IN	case	O
the	DT	det	O
foveal	JJ	amod	B-Tissue
avascular	JJ	amod	I-Tissue
zone	NN	nmod	I-Tissue
(	-LRB-	punct	O
FAZ	NN	appos	B-Tissue
)	-RRB-	punct	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
murine	JJ	amod	B-Organism
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubj	I-Multi-tissue_structure
contains	VBZ	ccomp	O
endothelial	JJ	amod	B-Cell
progenitors	NNS	dobj	I-Cell
,	,	punct	O
which	WDT	nsubj	O
arise	VBP	acl:relcl	O
from	IN	case	O
a	DT	det	O
cell	NN	nmod	B-Cell
with	IN	case	O
self	NN	npadvmod	O
-	HYPH	punct	O
renewing	VBG	amod	O
capacity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
can	MD	aux	O
integrate	VB	conj	O
into	IN	case	O
tumor	NN	compound	B-Tissue
microvasculature	NN	nmod	I-Tissue
,	,	punct	O
albeit	IN	mark	O
at	IN	case	O
a	DT	det	O
very	RB	advmod	O
low	JJ	amod	O
frequency	NN	nmod	O
.	.	punct	O

Statistically	RB	advmod	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
regarding	VBG	case	O
angiogenesis	NN	nmod	O
between	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
and	CC	cc	O
groups	NNS	conj	O
3	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
.	.	punct	O

Remarkably	RB	advmod	O
,	,	punct	O
lymphomas	NNS	nsubj	B-Cancer
arising	VBG	acl	O
in	IN	case	O
Trp53	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
(	-LRB-	punct	O
encoding	VBG	acl	O
p53R172P	NNS	advmod	B-Gene_or_gene_product
)	-RRB-	punct	O
retain	VBP	ROOT	O
stable	JJ	amod	O
genomes	NNS	dobj	O
.	.	punct	O

Down	NN	compound	O
-	HYPH	punct	O
regulation	NN	ROOT	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
XII	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
transformed	VBN	amod	O
mesenchymal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
detection	NN	nsubj	O
of	IN	case	O
increased	VBN	amod	O
abundance	NN	nmod	O
of	IN	case	O
EGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
R	NN	nmod	I-Gene_or_gene_product
or	CC	cc	O
Her	PRP$	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
neu	NN	compound	B-Gene_or_gene_product
proteins	NNS	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
tumours	NNS	nmod	B-Cancer
can	MD	aux	O
provide	VB	ROOT	O
additional	JJ	amod	O
information	NN	dobj	O
on	IN	case	O
the	DT	det	O
disease	NN	nmod:npmod	O
-	HYPH	punct	O
free	JJ	amod	O
survival	NN	nmod	O
and	CC	cc	O
overall	JJ	amod	O
survival	NN	conj	O
for	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
breast	NN	nmod	B-Cancer
,	,	punct	O
ovarian	JJ	conj	B-Cancer
,	,	punct	O
endometrial	JJ	conj	B-Cancer
or	CC	cc	O
cervical	JJ	conj	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

Immunohistochemically	RB	advmod	O
stained	JJ	ROOT	O
sections	NNS	nsubjpass	B-Cancer
of	IN	prep	O
tumour	NN	pobj	B-Cancer
were	VBD	auxpass	O
allocated	VBN	ccomp	O
a	DT	det	O
score	NN	dobj	O
for	IN	case	O
stain	NN	compound	O
intensity	NN	nmod	O
and	CC	cc	O
results	NNS	nsubj	O
correlated	VBD	conj	O
to	IN	nmod	O
:	:	punct	O
survival	NN	dobj	O
;	:	punct	O
tumour	NN	compound	B-Cancer
stage	NN	conj	O
(	-LRB-	punct	O
T	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
nodal	JJ	amod	B-Multi-tissue_structure
stage	NN	conj	O
(	-LRB-	punct	O
N	NN	appos	O
)	-RRB-	punct	O
;	:	punct	O
stage	NN	compound	O
grouping	NN	conj	O
(	-LRB-	punct	O
I	PRP	dep	O
to	TO	case	O
IIIb	NNS	nmod	O
)	-RRB-	punct	O
,	,	punct	O
survival	NN	compound	O
status	NN	conj	O
and	CC	cc	O
sex	NN	conj	O
.	.	punct	O

While	IN	mark	O
the	DT	det	O
study	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
as	IN	case	O
a	DT	det	O
phenomenon	NN	nmod	O
is	VBZ	cop	O
still	RB	advmod	O
in	IN	case	O
an	DT	det	O
early	JJ	amod	O
phase	NN	advcl	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
possible	JJ	acomp	O
,	,	punct	O
by	IN	mark	O
using	VBG	advcl	O
a	DT	det	O
combination	NN	dobj	O
of	IN	case	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	nmod	O
in	FW	amod	O
vivo	FW	dep	O
techniques	NNS	conj	O
,	,	punct	O
to	TO	mark	O
more	RBR	advmod	O
thoroughly	RB	advmod	O
understand	VB	conj	O
the	DT	det	O
initiation	NN	dobj	O
and	CC	cc	O
control	NN	conj	O
of	IN	case	O
capillary	JJ	amod	B-Tissue
growth	NN	nmod	O
.	.	punct	O

DATS	NN	nsubjpass	B-Simple_chemical
were	VBD	auxpass	O
injected	VBN	ROOT	O
once	RB	case	O
per	IN	case	O
four	CD	nummod	O
days	NNS	nmod	O
intraperitoneally	RB	advmod	B-Immaterial_anatomical_entity
(	-LRB-	punct	O
i	LS	dep	O
.	.	punct	O
p	NN	ROOT	O
.	.	punct	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	case	O
treatment	NN	nmod	O
starting	VBG	acl	O
4	CD	nummod	O
weeks	NNS	dobj	O
prior	RB	amod	O
to	TO	mwe	O
cells	NNS	compound	B-Cell
inoculation	NN	dep	O
.	.	punct	O

Early	JJ	amod	O
relapse	NN	nsubjpass	O
with	IN	case	O
distant	JJ	amod	O
metastasis	NN	nmod	O
often	RB	advmod	O
is	VBZ	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
patients	NNS	nmod	B-Organism
with	IN	case	O
cancer	NN	nmod	B-Cancer
after	IN	case	O
resection	NN	nmod	O
of	IN	case	O
the	DT	det	O
primary	JJ	amod	O
tumor	NN	nmod	B-Cancer
.	.	punct	O

A	DT	det	O
perifusion	NN	compound	O
system	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
in	IN	mark	O
order	NN	mwe	O
to	TO	mark	O
study	VB	advcl	O
glucose	NN	nsubj	B-Simple_chemical
and	CC	cc	O
glutamine	NN	compound	B-Amino_acid
metabolism	NN	conj	O
by	IN	case	O
freshly	RB	advmod	O
harvested	VBN	amod	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	conj	I-Cell
tumour	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
in	IN	case	O
steady	JJ	amod	O
state	NN	compound	O
conditions	NNS	nmod	O
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
positive	JJ	amod	O
relationship	NN	nsubj	O
between	IN	case	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nmod	O
and	CC	cc	O
N	NN	compound	O
-	HYPH	punct	O
stage	NN	conj	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	advcl	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	nsubj	O
)	-RRB-	punct	O
,	,	punct	O
presence	NN	dep	O
of	IN	case	O
nodal	JJ	amod	B-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	parataxis	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	dobj	O
)	-RRB-	punct	O
,	,	punct	O
stage	NN	compound	O
grouping	NN	attr	O
(	-LRB-	punct	O
p	NN	dep	O
=	JJ	amod	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
01	CD	nsubj	O
)	-RRB-	punct	O
and	CC	cc	O
extent	NN	conj	O
of	IN	case	O
disease	NN	nmod	O
(	-LRB-	punct	O
p	NN	nsubj	O
=	JJ	dep	O
<	SYM	dobj	O
0	CD	nummod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
total	JJ	amod	O
group	NN	nmod	O
and	CC	cc	O
the	DT	det	O
SCC	NN	compound	B-Cancer
subgroup	NN	conj	O
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
adenocarcinoma	NN	conj	B-Cancer
.	.	punct	O

The	DT	det	O
antiapoptotic	JJ	amod	O
effect	NN	nsubjpass	O
of	IN	case	O
FVIIa	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
the	DT	det	O
observation	NN	nmod	O
that	IN	mark	O
FVIIa	NN	nsubj	B-Gene_or_gene_product
attenuated	VBD	ccomp	O
caspase	NN	compound	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
activation	NN	dobj	O
.	.	punct	O

To	TO	mark	O
define	VB	advcl	O
these	DT	det	O
roles	NNS	dobj	O
more	RBR	advmod	O
clearly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
DCC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
ligand	NN	conj	O
,	,	punct	O
netrin	NN	appos	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
endometrium	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
in	IN	case	O
endometrial	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
increased	VBN	ROOT	O
with	IN	case	O
malignancy	NN	nmod	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
expression	NN	nsubjpass	O
of	IN	case	O
MMP	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
seen	VBN	conj	O
.	.	punct	O

We	PRP	nsubj	O
have	VBP	ROOT	O
,	,	punct	O
therefore	RB	advmod	O
,	,	punct	O
measured	VBD	parataxis	O
the	DT	det	O
mRNA	NN	compound	O
level	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
B	NNP	nmod	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	conj	I-Gene_or_gene_product
together	RB	advmod	O
with	IN	case	O
their	PRP$	nmod:poss	O
receptors	NNS	nmod	O
by	IN	case	O
RNase	NN	compound	B-Gene_or_gene_product
protection	NN	compound	O
assay	NN	nmod	O
(	-LRB-	punct	O
RPA	NN	appos	O
)	-RRB-	punct	O
in	IN	case	O
26	CD	nummod	O
normal	JJ	amod	B-Multi-tissue_structure
kidney	NN	compound	I-Multi-tissue_structure
samples	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
45	CD	nummod	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
evaluate	VB	dep	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
retinal	JJ	amod	B-Multi-tissue_structure
vasculature	NN	nmod	I-Multi-tissue_structure
overlying	NN	acl	O
pigment	NN	amod	B-Pathological_formation
epithelial	JJ	amod	I-Pathological_formation
detachments	NNS	dobj	I-Pathological_formation
(	-LRB-	punct	O
PED	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
in	IN	case	O
exudative	JJ	amod	O
age	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
ARMD	NN	appos	O
)	-RRB-	punct	O
using	VBG	acl	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
and	CC	cc	O
fluorescein	NN	conj	B-Simple_chemical
angiography	NN	dobj	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
importance	NN	nsubjpass	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	nmod	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
in	IN	case	O
renal	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
contribution	NN	nsubj	O
of	IN	case	O
these	DT	det	O
new	JJ	amod	O
ligands	NNS	nmod	O
in	IN	case	O
kidney	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
is	VBZ	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
Akt	NNP	nmod	B-Gene_or_gene_product
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
does	VBZ	aux	O
not	RB	neg	O
fully	RB	advmod	O
attenuate	VB	ROOT	O
p	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
downregulation	NN	dobj	O
of	IN	case	O
AR	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
,	,	punct	O
suggesting	VBG	advcl	O
that	IN	mark	O
inhibition	NN	nsubj	O
of	IN	case	O
AR	NN	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
by	IN	case	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nmod	I-Simple_chemical
does	VBZ	aux	O
not	RB	neg	O
occur	VB	ccomp	O
solely	RB	advmod	O
through	IN	case	O
alterations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
phosphatidylinositol	NN	compound	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
survival	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

The	DT	det	O
nature	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
substrates	NNS	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
proteolysis	NN	compound	O
techniques	NNS	nmod	O
.	.	punct	O

Induction	NN	nsubjpass	O
of	IN	case	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nmod	O
by	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	nmod	I-Gene_or_gene_product
was	VBD	auxpass	O
attenuated	VBN	ROOT	O
by	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ski	NNP	nmod	I-Gene_or_gene_product
in	FW	compound	O
vitro	FW	advmod	O
,	,	punct	O
and	CC	cc	O
expression	NN	nsubjpass	O
of	IN	case	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
mRNA	NN	nmod	O
was	VBD	auxpass	O
decreased	VBN	conj	O
in	IN	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ski	NNP	dobj	I-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
time	NN	ROOT	O
to	TO	case	O
disease	NN	compound	O
progression	NN	nmod	O
while	IN	mark	O
on	IN	case	O
treatment	NN	nmod	O
was	VBD	cop	O
24	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
paired	JJ	amod	O
tumour	NN	dobj	B-Cancer
and	CC	cc	O
normal	JJ	amod	O
-	HYPH	punct	O
tissue	NN	compound	B-Tissue
specimens	NNS	conj	I-Tissue
of	IN	case	O
86	CD	nummod	O
CRC	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
for	IN	case	O
the	DT	det	O
occurrence	NN	nmod	O
of	IN	case	O
aberrations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
mutation	NN	compound	O
cluster	NN	compound	O
region	NN	nmod	O
(	-LRB-	punct	O
MCR	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
exon	NN	conj	O
3	CD	nummod	O
of	IN	case	O
the	DT	det	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
-	HYPH	punct	O
single	JJ	amod	O
-	HYPH	punct	O
strand	NN	compound	O
conformation	NN	compound	O
polymorphism	NN	nmod	O
(	-LRB-	punct	O
PCR	NN	compound	O
-	:	punct	O
SSCP	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
PCR	NN	compound	O
-	HYPH	punct	O
direct	JJ	amod	O
sequencing	NN	conj	O
.	.	punct	O

Transfection	NN	nsubj	O
of	IN	case	O
full	JJ	amod	O
-	HYPH	punct	O
length	NN	compound	O
5T4	NN	compound	B-Gene_or_gene_product
cDNA	NN	nmod	O
into	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
alters	VBZ	ROOT	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
contacts	NNS	dobj	O
and	CC	cc	O
cellular	JJ	amod	B-Cell
motility	NN	conj	O
.	.	punct	O

Antiangiogenic	JJ	amod	O
properties	NNS	nsubjpass	O
have	VBP	aux	O
been	VBN	auxpass	O
recently	RB	advmod	O
reported	VBN	ROOT	O
in	IN	case	O
nicked	VBN	amod	B-Gene_or_gene_product
beta2GPI	NN	nmod	I-Gene_or_gene_product
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
intact	JJ	amod	O
beta2GPI	NN	conj	B-Gene_or_gene_product
at	IN	case	O
higher	JJR	amod	O
concentrations	NNS	nmod	O
.	.	punct	O

According	VBG	prep	O
to	IN	prep	O
these	DT	det	O
different	JJ	amod	O
functions	NNS	pobj	O
,	,	punct	O
the	DT	det	O
role	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NN	compound	I-Gene_or_gene_product
protein	NN	nmod	O
in	IN	case	O
cellular	JJ	amod	B-Cell
sensitivity	NN	nmod	O
to	TO	case	O
anti	VB	amod	O
-	HYPH	punct	O
cancer	NN	compound	B-Cancer
drugs	NNS	nmod	O
is	VBZ	cop	O
controversial	JJ	ROOT	O
.	.	punct	O

As	IN	case	O
a	DT	det	O
result	NN	nmod	O
of	IN	case	O
paracrine	NN	amod	O
signal	NN	compound	O
transmission	NN	nmod	O
,	,	punct	O
the	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
signaling	NN	nmod	O
most	RBS	advmod	O
profoundly	RB	advmod	O
influence	VBP	ROOT	O
the	DT	det	O
stromal	JJ	amod	B-Cell
cells	NNS	dobj	I-Cell
that	WDT	nsubj	O
constitute	VBP	acl:relcl	O
the	DT	det	O
tumor	NN	compound	B-Cancer
microenvironment	NN	dobj	O
.	.	punct	O

After	IN	case	O
MNNG	NN	compound	B-Simple_chemical
administration	NN	nmod	O
,	,	punct	O
rats	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	case	O
endoscopic	JJ	amod	O
observation	NN	nmod	O
,	,	punct	O
visualization	NN	appos	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
structure	NN	nmod	O
,	,	punct	O
and	CC	cc	O
estimation	NN	conj	O
of	IN	case	O
lectin	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

Syndecan	NNP	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	compound	I-Cellular_component
proteoglycan	NN	ROOT	O
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
implicated	VBN	acl:relcl	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
cellular	JJ	amod	B-Cell
functions	NNS	nmod	O
including	VBG	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
adhesion	NN	nmod	O
,	,	punct	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
matrix	NN	compound	B-Cellular_component
anchorage	NN	conj	O
and	CC	cc	O
growth	NN	compound	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
presentation	NN	conj	O
for	IN	case	O
signalling	NN	amod	O
receptors	NNS	nmod	O
.	.	punct	O

Membrane	NNP	npadvmod	O
-	HYPH	punct	O
anchored	VBN	amod	O
Cbl	NN	nsubj	B-Gene_or_gene_product
suppresses	VBZ	ROOT	O
Hck	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
-	HYPH	punct	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod:npmod	O
mediated	JJ	amod	O
cellular	JJ	amod	B-Cell
transformation	NN	dobj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
bundle	NN	compound	I-Multi-tissue_structure
implantation	NN	nmod	O
in	IN	case	O
autogenous	JJ	amod	B-Multi-tissue_structure
bone	NN	compound	I-Multi-tissue_structure
graft	NN	nmod	I-Multi-tissue_structure
on	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
current	JJ	amod	O
investigation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nsubj	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
an	DT	det	O
equivalent	JJ	amod	O
dose	NN	conj	O
of	IN	case	O
SM	NN	nmod	B-Simple_chemical
,	,	punct	O
alters	VBZ	ccomp	O
molecular	JJ	amod	O
targets	NNS	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
androgen	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
responsive	JJ	amod	O
LNCaP	NN	nmod	B-Cell
and	CC	cc	O
androgen	NN	compound	B-Simple_chemical
-	HYPH	punct	O
independent	JJ	amod	O
LNCaP	NN	compound	B-Cell
C4	NN	compound	I-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
human	JJ	amod	I-Cell
prostate	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

Staining	NN	nsubj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
mammary	JJ	amod	B-Tissue
epithelium	NN	nmod	I-Tissue
,	,	punct	O
if	IN	mark	O
present	JJ	advcl	O
,	,	punct	O
was	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
than	IN	mark	O
observed	VBN	advcl	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
the	DT	det	O
same	JJ	amod	O
patient	NN	nmod	B-Organism
.	.	punct	O

To	TO	mark	O
prevent	VB	advcl	O
adhesions	NNS	dobj	O
,	,	punct	O
an	DT	det	O
experimental	JJ	amod	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
planned	VBN	ROOT	O
to	TO	mark	O
designate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
low	JJ	amod	B-Simple_chemical
molecular	JJ	amod	I-Simple_chemical
weight	NN	compound	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
LMW	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
heparins	NNS	nmod	I-Simple_chemical
and	CC	cc	O
hyperbaric	JJ	amod	B-Simple_chemical
oxygen	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
HBO	NN	compound	B-Simple_chemical
)	-RRB-	punct	O
therapy	NN	conj	O
both	CC	cc:preconj	O
on	IN	case	O
the	DT	det	O
formation	NN	nmod	O
of	IN	case	O
adhesions	NNS	nmod	O
and	CC	cc	O
wound	NN	compound	B-Pathological_formation
healing	NN	conj	O
.	.	punct	O

Somatic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
hybrids	NNS	nsubj	I-Cell
between	IN	case	O
LTA	NN	nmod	B-Cell
and	CC	cc	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	conj	I-Cell
are	VBP	cop	O
tumorigenic	JJ	ROOT	O
,	,	punct	O
metastatic	JJ	conj	O
and	CC	cc	O
ras	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
responsive	JJ	conj	O
.	.	punct	O

Using	VBG	advcl	O
wound	NN	compound	B-Pathological_formation
-	HYPH	punct	O
healing	NN	compound	O
assay	NN	dobj	O
and	CC	cc	O
Boyden	NN	compound	O
chamber	NN	compound	O
assay	NN	conj	O
,	,	punct	O
GA	NN	nsubj	B-Simple_chemical
had	VBD	ROOT	O
potent	JJ	amod	O
inhibitory	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
AGS	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

BMECs	NNS	nsubj	B-Cell
transfected	VBN	acl	O
with	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product
alone	RB	advmod	O
were	VBD	cop	O
functionally	RB	advmod	O
and	CC	advmod	O
phenotypically	RB	advmod	O
normal	JJ	ROOT	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
also	RB	advmod	O
an	DT	det	O
implicit	JJ	amod	O
assumption	NN	attr	O
that	IN	mark	O
a	DT	det	O
mechanistic	JJ	amod	O
understanding	NN	nsubj	O
,	,	punct	O
although	IN	mark	O
fundamentally	RB	advmod	O
reductionist	NN	advcl	O
,	,	punct	O
will	MD	aux	O
nonetheless	RB	advmod	O
lead	VB	ccomp	O
to	TO	prep	O
a	DT	det	O
more	RBR	advmod	O
profound	JJ	amod	O
teleological	JJ	amod	O
understanding	NN	pobj	O
of	IN	prep	O
the	DT	det	O
need	NN	pobj	O
for	IN	case	O
altered	JJ	amod	O
metabolism	NN	nmod	O
in	IN	case	O
invasive	JJ	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
defined	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	nmod	I-Gene_or_gene_product
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
sensitivity	NN	nmod	O
to	TO	case	O
vinblastine	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
VLB	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
using	VBG	acl	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
:	:	punct	O
LoVo	NN	compound	B-Cell
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	dobj	O
or	CC	cc	O
transfected	VBN	conj	O
with	IN	case	O
a	DT	det	O
plasmid	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-Organism
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
gene	NN	dobj	O
in	IN	case	O
antisense	JJ	amod	O
orientation	NN	nmod	O
(	-LRB-	punct	O
LoVo	NN	compound	B-Cell
-	:	punct	I-Cell
mycANS	NN	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
We	PRP	nsubj	O
present	VBP	dep	O
initial	JJ	amod	O
results	NNS	dobj	O
demonstrating	VBG	acl	O
anti	JJ	amod	O
-	HYPH	punct	O
inflammatory	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
spironolactone	NN	nmod	B-Simple_chemical
.	.	punct	O

OBJECT	NN	dep	O
:	:	punct	O
Endothelial	JJ	amod	B-Cell
proliferation	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
recognized	VBN	ROOT	O
as	IN	case	O
a	DT	det	O
marker	NN	nmod	O
of	IN	case	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	nmod	O
or	CC	cc	O
aggressive	JJ	amod	O
glioma	NN	conj	B-Cancer
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
HCMV	NN	nsubj	B-Organism
elevates	VBZ	ccomp	O
cellular	JJ	amod	B-Cell
p53	NN	compound	B-Gene_or_gene_product
levels	NNS	dobj	O
on	IN	case	O
the	DT	det	O
order	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
-	HYPH	punct	O
to	IN	quantmod	O
20	CD	nummod	O
-	HYPH	punct	O
fold	JJ	nmod	O
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
FVIIa	NN	nsubj	B-Gene_or_gene_product
binding	VBG	acl	O
to	TO	case	O
TF	NN	nmod	B-Gene_or_gene_product
provided	VBD	ROOT	O
protection	NN	dobj	O
against	IN	case	O
apoptosis	NN	nmod	O
induced	VBN	acl	O
by	IN	case	O
growth	NN	compound	O
factor	NN	compound	O
deprivation	NN	nmod	O
,	,	punct	O
primarily	RB	advmod	O
through	IN	case	O
activation	NN	nmod	O
of	IN	case	O
PI3	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
/	:	punct	O
Akt	NN	compound	B-Gene_or_gene_product
pathway	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	case	O
a	DT	det	O
lesser	JJR	amod	O
extent	NN	conj	O
,	,	punct	O
p44	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
42	CD	nummod	I-Gene_or_gene_product
MAPK	NN	compound	I-Gene_or_gene_product
pathway	NN	appos	O
.	.	punct	O

1	LS	nummod	B-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phenylenebis	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
methylene	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
selenocyanate	NN	nsubj	I-Simple_chemical
,	,	punct	O
but	CC	cc	O
not	RB	cc	O
selenomethionine	NN	conj	B-Simple_chemical
,	,	punct	O
inhibits	VBZ	ROOT	O
androgen	NN	compound	B-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
Akt	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Bcl	NN	nsubj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
protected	VBD	ROOT	O
SH	NN	compound	B-Cell
-	HYPH	punct	I-Cell
EP	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
from	IN	case	O
death	NN	nmod	O
during	IN	case	O
nutritional	JJ	amod	O
deprivation	NN	nmod	O
by	IN	mark	O
activating	VBG	advcl	O
energetically	RB	advmod	O
advantageous	JJ	amod	O
oxidative	JJ	amod	O
phosphorylation	NN	dobj	O
.	.	punct	O

Somatostatin	NN	compound	B-Gene_or_gene_product
receptors	NNS	nsubjpass	I-Gene_or_gene_product
were	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
peritumoral	JJ	amod	B-Multi-tissue_structure
veins	NNS	nmod	I-Multi-tissue_structure
of	IN	case	O
various	JJ	amod	O
human	JJ	amod	B-Organism
cancer	NN	compound	B-Tissue
tissue	NN	compound	I-Tissue
specimens	NNS	nmod	I-Tissue
.	.	punct	O

Systemic	JJ	amod	O
administration	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
LPS	NN	conj	B-Simple_chemical
in	IN	case	O
adult	JJ	amod	O
mice	NNS	nmod	B-Organism
resulted	VBD	ROOT	O
in	IN	case	O
cyclosporine	NN	compound	B-Simple_chemical
A	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	amod	O
reactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
DSCR1s	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
and	CC	cc	O
endogenous	JJ	amod	O
gene	NN	compound	O
expression	NN	conj	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
organs	NNS	nmod	B-Organ
,	,	punct	O
including	VBG	prep	O
the	DT	det	O
heart	NN	pobj	B-Organ
and	CC	cc	O
brain	NN	conj	B-Organ
.	.	punct	O

These	DT	det	O
transcripts	NNS	nsubj	O
were	VBD	auxpass	O
localized	JJ	ROOT	O
in	IN	case	O
stromal	JJ	amod	B-Cell
fibroblasts	NNS	nmod	I-Cell
adjacent	JJ	amod	O
to	TO	case	O
the	DT	det	O
neoplastic	JJ	amod	O
foci	NNS	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	compound	I-Gene_or_gene_product
expression	NN	nsubj	O
was	VBD	cop	O
higher	JJR	appos	O
in	IN	case	O
lymphatic	JJ	amod	B-Organ
metastasis	NN	compound	O
group	NN	nmod	O
(	-LRB-	punct	O
PI	NN	dep	O
=	JJ	amod	O
12	CD	dobj	O
.	.	punct	O
169	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
2	CD	nummod	O
.	.	punct	O
778	CD	ROOT	O
)	-RRB-	punct	O
than	IN	case	O
in	IN	case	O
no	DT	nummod	O
-	HYPH	punct	O
metastasis	NN	compound	O
group	NN	advcl	O
(	-LRB-	punct	O
PI	NN	dep	O
=	JJ	amod	O
8	CD	dobj	O
.	.	punct	O
498	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
2	CD	ROOT	O
.	.	punct	O
674	CD	dep	O
,	,	punct	O
P	NN	compound	O
<	-LRB-	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

Efficient	JJ	amod	O
inhibition	NN	ROOT	O
of	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
growth	NN	nmod	O
and	CC	cc	O
prolonged	JJ	amod	O
survival	NN	conj	O
by	IN	case	O
transfection	NN	nmod	O
with	IN	case	O
a	DT	det	O
novel	JJ	amod	O
pro	NN	compound	O
-	HYPH	punct	O
apoptotic	JJ	amod	O
gene	NN	nmod	O
,	,	punct	O
hPNAS	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	appos	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
a	DT	det	O
mouse	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

TESTING	VBG	compound	O
THE	DT	compound	O
HYPOTHESIS	NN	dep	O
:	:	punct	O
Stimulation	NN	nsubjpass	O
of	IN	case	O
dormant	JJ	amod	B-Cancer
micrometastases	NNS	nmod	I-Cancer
by	IN	case	O
primary	JJ	amod	O
tumor	NN	compound	B-Cancer
removal	NN	nmod	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
occur	VB	xcomp	O
in	IN	case	O
animal	NN	compound	O
models	NNS	nmod	O
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
,	,	punct	O
combined	VBN	acl	O
with	IN	case	O
new	JJ	amod	O
molecular	JJ	amod	O
insights	NNS	nmod	O
with	IN	case	O
HIF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1alpha	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	conj	I-Gene_or_gene_product
,	,	punct	O
have	VBP	aux	O
rekindled	VBN	ROOT	O
an	DT	det	O
interest	NN	dobj	O
in	IN	case	O
this	DT	det	O
important	JJ	amod	O
phenotype	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
only	RB	advmod	O
further	JJ	amod	O
research	NN	nsubj	O
will	MD	aux	O
determine	VB	advcl	O
the	DT	det	O
exact	JJ	amod	O
nature	NN	dobj	O
of	IN	case	O
VEGF	NN	compound	B-Gene_or_gene_product
'	POS	punct	O
s	VBZ	compound	O
role	NN	nmod	O
after	IN	case	O
seizures	NNS	nmod	O
,	,	punct	O
preliminary	JJ	amod	O
data	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
VEGF	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
protective	JJ	amod	O
role	NN	dobj	O
after	IN	case	O
seizures	NNS	nmod	O
.	.	punct	O

In	IN	case	O
conclusion	NN	nmod	O
,	,	punct	O
GA	NNP	nsubj	B-Simple_chemical
may	MD	aux	O
have	VB	ROOT	O
the	DT	det	O
potential	NN	dobj	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
effective	JJ	amod	O
agent	NN	xcomp	O
for	IN	case	O
prevention	NN	nmod	O
and	CC	cc	O
treatment	NN	conj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
cancer	NN	compound	I-Cancer
metastasis	NN	nmod	O
.	.	punct	O

The	DT	det	O
prosurvival	NN	compound	O
autophagic	JJ	amod	O
response	NN	nsubjpass	O
of	IN	case	O
myeloma	NN	nmod	B-Cancer
to	TO	mark	O
nutrient	JJ	acl	O
deprivation	NN	dobj	O
or	CC	cc	O
to	TO	case	O
nucleoside	NN	compound	B-Simple_chemical
analogue	NN	compound	I-Simple_chemical
treatment	NN	conj	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	auxpass	O
described	VBN	ROOT	O
previously	RB	advmod	O
.	.	punct	O

LVI	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
axillary	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
ALNM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
prognostic	JJ	amod	O
factor	NN	conj	O
.	.	punct	O

Spontaneous	JJ	amod	O
metastasis	NN	nsubj	O
indicates	VBZ	ROOT	O
a	DT	det	O
possible	JJ	amod	O
reverse	JJ	amod	O
correlation	NN	dobj	O
.	.	punct	O

Formation	NN	nsubjpass	O
of	IN	case	O
apoptotic	JJ	amod	B-Cellular_component
bodies	NNS	nmod	I-Cellular_component
was	VBD	auxpass	O
preceded	VBN	ROOT	O
by	IN	case	O
lowering	VBG	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
polyamines	NNS	nmod	O
,	,	punct	O
particularly	RB	advmod	O
putrescine	NN	appos	B-Simple_chemical
,	,	punct	O
and	CC	cc	O
both	DT	cc:preconj	O
dose	NN	conj	O
-	:	punct	O
and	CC	cc	O
time	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
inhibitory	JJ	conj	O
and	CC	cc	O
activation	NN	conj	O
effect	NN	dep	O
by	IN	case	O
ACA	NN	nmod	B-Simple_chemical
on	IN	case	O
ornithine	NN	compound	B-Gene_or_gene_product
decarboxylase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
ODC	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
spermidine	NN	compound	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
spermine	NN	compound	I-Gene_or_gene_product
N	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
acetyltransferase	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
SSAT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
respectively	RB	advmod	O
.	.	punct	O

Autochthonous	JJ	amod	O
vessels	NNS	nsubj	B-Multi-tissue_structure
surrounding	VBG	acl	O
other	JJ	amod	O
tumors	NNS	dobj	B-Cancer
such	JJ	case	O
as	IN	mwe	O
renal	JJ	amod	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
or	CC	cc	O
malignant	JJ	amod	B-Cancer
lymphomas	NNS	conj	I-Cancer
also	RB	advmod	O
frequently	RB	advmod	O
expressed	VBD	ROOT	O
somatostatin	NN	compound	B-Gene_or_gene_product
receptors	NNS	dobj	I-Gene_or_gene_product
.	.	punct	O

A	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
mutant	NN	nsubj	O
,	,	punct	O
p53R172P	NN	appos	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
deficient	JJ	acl:relcl	O
for	IN	case	O
apoptosis	NN	nmod	O
but	CC	cc	O
retains	VBZ	conj	O
a	DT	det	O
partial	JJ	amod	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	compound	O
function	NN	dobj	O
,	,	punct	O
delays	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Our	PRP$	nmod:poss	O
in	FW	amod	O
vitro	FW	dep	O
studies	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
NIH3T3	NN	compound	B-Cell
cells	NNS	nsubj	I-Cell
overexpressing	VBG	acl	O
BI	NN	dobj	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
displayed	VBD	ccomp	O
a	DT	det	O
significantly	RB	advmod	O
higher	JJR	amod	O
growth	NN	compound	O
rate	NN	dobj	O
and	CC	cc	O
formed	VBD	conj	O
more	JJR	amod	O
and	CC	cc	O
larger	JJR	conj	O
colonies	NNS	dobj	O
than	IN	case	O
the	DT	det	O
control	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
proliferative	JJ	amod	O
response	NN	nsubj	O
of	IN	case	O
bovine	JJ	amod	B-Organism
retinal	JJ	amod	B-Cell
capillary	JJ	amod	I-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
EGF	NN	nmod	B-Gene_or_gene_product
is	VBZ	cop	O
dependent	JJ	ROOT	O
upon	IN	mark	O
attaching	VBG	advcl	O
the	DT	det	O
cells	NNS	dobj	B-Cell
to	TO	case	O
a	DT	det	O
matrix	NN	nmod	B-Cellular_component
of	IN	case	O
fibronectin	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
reveals	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
HMGA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
regulation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
telomerase	NN	compound	B-Gene_or_gene_product
reverse	JJ	compound	I-Gene_or_gene_product
transcriptase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
hTERT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
catalytic	JJ	amod	O
subunit	NN	appos	O
of	IN	case	O
telomerase	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
offers	VBZ	acl:relcl	O
critical	JJ	amod	O
insight	NN	dobj	O
into	IN	mark	O
how	WRB	advmod	O
HMGA2	NN	nsubj	B-Gene_or_gene_product
contributes	VBZ	advcl	O
to	TO	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

Consistent	JJ	advmod	O
with	IN	case	O
these	DT	det	O
findings	NNS	nmod	O
is	VBZ	cop	O
the	DT	det	O
induction	NN	ROOT	O
under	IN	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
of	IN	case	O
the	DT	det	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
protein	NN	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Crk	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Rac1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	nmod	O
and	CC	cc	O
Rap1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
nascent	JJ	amod	B-Cellular_component
focal	JJ	amod	I-Cellular_component
complex	NN	compound	I-Cellular_component
stabilization	NN	conj	O
contributing	VBG	acl	O
to	TO	case	O
ephrin	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
B1	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
human	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

The	DT	det	O
ability	NN	nsubj	O
of	IN	case	O
E7	NN	nmod	B-Gene_or_gene_product
to	TO	case	O
complex	NN	nmod	O
with	IN	case	O
p600	NN	nmod	B-Gene_or_gene_product
correlated	VBD	ROOT	O
with	IN	case	O
its	PRP$	nmod:poss	O
ability	NN	nmod	O
to	TO	mark	O
enhance	VB	acl	O
anchorage	JJ	amod	O
independence	NN	dobj	O
of	IN	case	O
BPV	NN	compound	B-Organism
-	:	punct	O
1	CD	nummod	O
E6	NN	dep	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Patients	NNS	nsubj	B-Organism
had	VBD	aux	O
primarily	RB	advmod	O
relapsed	VBN	ROOT	O
diffuse	JJ	amod	O
large	JJ	amod	O
B	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
cell	NN	compound	I-Cancer
lymphoma	NN	nsubjpass	I-Cancer
(	-LRB-	punct	O
63	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
were	VBD	auxpass	O
heavily	RB	advmod	O
pretreated	VBN	advcl	O
(	-LRB-	punct	O
median	NN	dep	O
of	IN	case	O
three	CD	nummod	O
regimens	NNS	nmod	O
)	-RRB-	punct	O
and	CC	cc	O
high	JJ	amod	O
risk	NN	conj	O
(	-LRB-	punct	O
79	CD	nummod	O
%	NN	compound	O
international	JJ	amod	O
prognostic	JJ	amod	O
index	NN	dep	O
,	,	punct	O
greater	JJR	amod	O
than	IN	prep	O
or	CC	cc	O
=	JJ	conj	O
2	CD	nummod	O
)	-RRB-	punct	O
and	CC	cc	O
34	CD	nummod	O
%	NN	nsubjpass	O
were	VBD	auxpass	O
relapsed	VBN	conj	O
after	IN	case	O
autologous	JJ	amod	O
stem	NN	compound	B-Cell
cell	NN	compound	I-Cell
transplant	JJ	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Endometrial	JJ	amod	B-Multi-tissue_structure
glands	NNS	nsubj	I-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
and	CC	cc	O
early	JJ	conj	O
secretory	JJ	amod	O
phase	NN	nmod	O
expressed	VBD	appos	O
both	CC	cc:preconj	O
DCC	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
glands	NNS	conj	B-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
late	JJ	amod	O
-	HYPH	punct	O
secretory	JJ	amod	O
phase	NN	nmod	O
tended	VBD	conj	O
to	TO	mark	O
silence	VB	xcomp	O
DCC	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

Multiple	JJ	amod	O
myeloma	NN	nsubjpass	B-Cancer
,	,	punct	O
an	DT	det	O
incurable	JJ	amod	O
plasma	NN	compound	B-Cancer
cell	NN	compound	I-Cancer
malignancy	NN	appos	I-Cancer
,	,	punct	O
is	VBZ	auxpass	O
characterized	VBN	ROOT	O
by	IN	case	O
altered	JJ	amod	O
cellular	JJ	amod	B-Cell
metabolism	NN	nmod	O
and	CC	cc	O
resistance	NN	conj	O
to	TO	case	O
apoptosis	NN	nmod	O
.	.	punct	O

p21	NN	nsubj	B-Gene_or_gene_product
delays	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
by	IN	case	O
preservation	NN	nmod	O
of	IN	case	O
chromosomal	JJ	amod	B-Cellular_component
stability	NN	nmod	O
.	.	punct	O

Although	IN	mark	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nsubjpass	I-Simple_chemical
is	VBZ	auxpass	O
often	RB	advmod	O
used	VBN	advcl	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
oral	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
there	EX	expl	O
has	VBZ	aux	O
not	RB	neg	O
been	VBN	ROOT	O
any	DT	det	O
investigation	NN	nsubj	O
into	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
these	DT	det	O
enzymes	NNS	nmod	O
in	IN	case	O
metastatic	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
or	CC	cc	O
of	IN	case	O
their	PRP$	nmod:poss	O
roles	NNS	conj	O
in	IN	case	O
the	DT	det	O
effectiveness	NN	nmod	O
of	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod	I-Simple_chemical
in	IN	mark	O
treating	VBG	advcl	O
lymph	NN	compound	B-Cancer
node	NN	nmod:npmod	I-Cancer
-	HYPH	punct	I-Cancer
metastatic	JJ	amod	I-Cancer
cancer	NN	dobj	I-Cancer
.	.	punct	O

Detection	NN	ROOT	O
of	IN	case	O
lymphovascular	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
in	IN	case	O
early	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
by	IN	case	O
D2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
40	CD	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
podoplanin	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
:	:	punct	O
a	DT	det	O
clinically	RB	advmod	O
useful	JJ	amod	O
predictor	NN	dep	O
for	IN	case	O
axillary	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
point	NN	compound	O
mutations	NNS	nsubjpass	O
in	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product
are	VBP	auxpass	O
not	RB	neg	O
associated	VBN	ccomp	O
with	IN	case	O
pituitary	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
point	NN	compound	O
mutations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
H	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
important	JJ	parataxis	O
in	IN	case	O
the	DT	det	O
formation	NN	nmod	O
and	CC	cc	O
or	CC	cc	O
growth	NN	conj	O
of	IN	case	O
pituitary	JJ	amod	B-Cancer
metastases	NNS	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Loss	NN	nsubj	O
of	IN	case	O
heterozygosity	NN	nmod	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
FBXW7	NN	nmod	B-Gene_or_gene_product
occurred	VBD	appos	O
in	IN	case	O
32	CD	nummod	O
%	NN	nmod	O
of	IN	case	O
EOGCs	NNS	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
correlated	VBD	conj	O
with	IN	case	O
loss	NN	nmod	O
of	IN	case	O
expression	NN	nmod	O
in	IN	case	O
26	CD	nummod	O
%	NN	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
implication	NN	dobj	O
of	IN	case	O
stromelysin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
ST3	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
newly	RB	advmod	O
identified	VBN	amod	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
matrix	NN	compound	O
-	HYPH	punct	O
degrading	VBG	amod	O
metalloproteinase	NN	compound	O
family	NN	nmod	O
,	,	punct	O
and	CC	cc	O
of	IN	case	O
BM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
40	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
SPARC	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
glycoprotein	NN	appos	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
,	,	punct	O
during	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

Treatment	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
with	IN	case	O
PKC	NN	compound	B-Gene_or_gene_product
inhibitors	NNS	nmod	O
also	RB	advmod	O
potentiated	VBD	ROOT	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
of	IN	case	O
BPDE	NN	compound	B-Simple_chemical
treated	JJ	amod	O
cells	NNS	nmod	B-Cell
on	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
.	.	punct	O

Hypothesis	NN	ROOT	O
:	:	punct	O
Induced	VBN	amod	O
angiogenesis	NN	nsubj	O
after	IN	case	O
surgery	NN	nmod	O
in	IN	case	O
premenopausal	JJ	amod	O
node	NN	compound	O
-	HYPH	punct	O
positive	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
patients	NNS	nmod	B-Organism
is	VBZ	cop	O
a	DT	det	O
major	JJ	amod	O
underlying	JJ	amod	O
reason	NN	dep	O
why	WRB	advmod	O
adjuvant	JJ	amod	O
chemotherapy	NN	nsubj	O
works	VBZ	ccomp	O
particularly	RB	advmod	O
well	RB	advmod	O
for	IN	case	O
those	DT	det	O
patients	NNS	nmod	B-Organism
.	.	punct	O

